Cargando…
The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies
For patients with hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM) or arrhythmogenic cardiomyopathy (ACM), screening for pathogenic variants has become standard clinical practice. Genetic cascade screening also allows the identification of relatives that carry the same mutation as the...
Autores principales: | Stege, Nienke M., de Boer, Rudolf A., van den Berg, Maarten P., Silljé, Herman H. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998409/ https://www.ncbi.nlm.nih.gov/pubmed/33799487 http://dx.doi.org/10.3390/ijms22062955 |
Ejemplares similares
-
Telehealth’s Time Has Come
por: Waldrop, Julee B.
Publicado: (2020) -
Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)–Related Cardiomyopathy: Development of PLN-R14del–Related Cardiomyopathy
por: Eijgenraam, Tim R., et al.
Publicado: (2021) -
Patient-focused pathogen genetic counselling—has the time come?
por: Ferdinand, Angeline S, et al.
Publicado: (2021) -
The Time Has Come; One Year Has Passed
por: Heidary, Fatemeh, et al.
Publicado: (2013) -
An idea whose time has come
por: Banci, Lucia, et al.
Publicado: (2007)